StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY)

StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note published on Saturday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % Shares of NYSE:NBY opened at $0.13 on Friday. NovaBay Pharmaceuticals has a 12 month low of $0.07 and a 12 […]

Related Keywords

United States , ,Novabay Pharmaceuticals Inc ,Exchange Commission ,Armistice Capital ,Novabay Pharmaceuticals Stock Down ,News Ratings For Novabay Pharmaceuticals Daily ,Institutional Investors Weigh In On Novabay Pharmaceuticals ,Novabay Pharmaceuticals Company Profile ,Novabay Pharmaceuticals ,Free Report ,Bay Pharmaceuticals Stock Down ,Bay Pharmaceuticals ,Get Free Report ,Avenova Spray ,Novabay Pharmaceuticals Daily ,